ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
Conference on Nuclear Training and Education: A Biennial International Forum (CONTE 2025)
February 3–6, 2025
Amelia Island, FL|Omni Amelia Island Resort
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jan 2025
Jul 2024
Latest Journal Issues
Nuclear Science and Engineering
February 2025
Nuclear Technology
Fusion Science and Technology
Latest News
Feinstein Institutes to research novel radiation countermeasure
The Feinstein Institutes for Medical Research, home of the research institutes of New York’s Northwell Health, announced it has received a five-year, $2.9 million grant from the National Institutes of Health to investigate the potential of human ghrelin, a naturally occurring hormone, as a medical countermeasure against radiation-induced gastrointestinal syndrome (GI-ARS).
Technical Session
Monday, July 22, 2024|1:00–2:50PM CDT|Senate A/B
Session Chair:
Arnold Lumsdaine
Session Organizer:
Alternate Chair:
Ross F. Radel
To access paper attachments, you must be logged in and registered for the meeting.
Register NowLog In
Current Status of the Commissioning of Kyoto Fusioneering's Unique Integrated Testing facilitY (UNITY-1)
1:00–1:25PM CDT
S. Ogawa (Kyoto Fusioneering), K. Namba (Kyoto Fusioneering), N. Seki (Kyoto Fusioneering), T. Sugiyama (Kyoto Fusioneering), K. Tanaka (Kyoto Fusioneering), Y. Matsunaga (Kyoto Fusioneering), Y. Kume (Kyoto Fusioneering), C. Baus (Kyoto Fusioneering), S. Konishi (Kyoto Fusioneering)
Paper
Operation of a State-Licensed Multi-Gram Tritium Facility to Support DT Fusion Linear Accelerator for Radiation Effects (FLARE)
1:25–1:50PM CDT
C. Fagan (Torion Techologies), C.R. Shmayda (Torion Plasma Corp.), W.T. Shmayda (Tritium Solutions), C. Balke (SHINE Technologies), R.F. Radel (SHINE Technologies)
DIII-D Plasma-Interacting Technology Program to Support Industrial Fusion Pilot Plant Development: Capabilities, Progress, and Goals
1:50–2:10PM CDT
T. Abrams (General Atomics), A. Dvorak (ORNL), R. Buttery (General Atomics), M. Cengher (MIT), J.D. Coburn (Sandia), J. Herfindal (ORNL), S-H Hong (General Atomics), C. Petty (General Atomics), D.L. Rudakov (Univ. of California, San Diego), B. Van Compernolle (General Atomics), M. Van Zeeland (General Atomics)
Hydrogen Experiment for Real-time Analysis (HERA): Addressing the Challenges of Tritium Gas Analysis
2:10–2:30PM CDT
Lyn McWilliam (UKAEA), Richard Mather (UKAEA), Joseph Large (Jacobs), Adam Cooper (UKAEA)
Tritium Breeding Testing with an Intense DT Neutron Source
2:30–2:50PM CDT
Ross Radel (SHINE Technologies), Lucas Jacobson (SHINE Technologies), Laine Reusch (SHINE Technologies)
To join the conversation, you must be logged in and registered for the meeting.
